Home / Health News / Manufacturers of Medical Devices to Meet Risk Proportionate Regulatory Requirements

Manufacturers of Medical Devices to Meet Risk Proportionate Regulatory Requirements

The Health Ministry has notified the Medical Devices Rule, 2017 by which producers of clinical gadgets will likely be required to meet possibility proportionate regulatory necessities.

Manufacturers of Medical Devices to Meet Risk Proportionate Regulatory Requirements


The new laws framed in conformity with Global Harmonisation Task Force (GHTF) classifies clinical gadgets in response to related dangers, into Class A (low possibility), Class B (low average possibility), Class C (average top possibility) and Class D (top possibility), stated a remark.

‘Manufacture of Class A and Class B medical devices will be licenced by State Licensing Authorities concerned after Quality Management System audit by an accredited Notified Body.’

“With a view to bring in the highest degree of professionalism in regulation of medical devices, a system of ‘Third Party Conformity Assessment and Certification’ through Notified Bodies is envisaged,” stated the remark.

According to the well being ministry, the Notified Bodies will likely be authorised via the National Accreditation Board for Certification Bodies (NABCB).

Currently, simplest 15 classes of clinical gadgets are regulated as medicine and to that extent, the present regulatory practices in India weren’t absolutely geared to meet the necessities of the clinical gadgets sector within the nation.

The new laws search to take away regulatory bottlenecks to make in India, facilitate ease of doing trade whilst making sure availability of higher clinical gadgets for affected person care and protection.

“The manufacturer will, in such a case, be required to do self-certification of compliance with the requirements and based on such certification, the licence will be issued,” the well being ministry remark stated.

“Manufacture of Class A and Class B medical devices will be licenced by State Licensing Authorities concerned after Quality Management System audit by an accredited Notified Body,” stated the remark, including that for all production websites, Quality Management System will want to be aligned with ISO 13485.

“Manufacture of Class C and Class D medical devices will be regulated by the Central Licensing Authority and, where required, assistance of experts or notified bodies will be taken. Import of all medical devices will continue to be regulated by Central Drugs Standard Control Organization. A network of NABL accredited laboratories will be set up both, by the government and by other entities, for testing medical devices,” stated the ministry.

Conduct of scientific investigations will, whilst following the global practices, be performed in a fashion that guarantees realisation of the dual goals of affected person protection and welfare and discovery of new clinical gadgets.

Source: IANS

About Aadam

Check Also

hepatitis c drug sofosbuvir 300x165 - India Grants Patent for Gilead's Hepatitis C Drug

India Grants Patent for Gilead's Hepatitis C Drug

US pharmaceutical massive Gilead has acquired a patent for its Hepatitis C drug from India. …

Leave a Reply

Your email address will not be published. Required fields are marked *